Closed revenue, not pipeline stages
Rank channels by the revenue they closed rather than the opportunities they created.
For Pharma & Life Sciences
Which channels produced ordering accounts?
Match ordering accounts and their repeat revenue to the campaigns, congresses and content that produced the first order.
No card required · Nothing to install · Cancel anytime
The blind spot
What's actually happening
Life sciences purchasing is repeat, catalogue-driven and institutional. First-order attribution describes a fraction of what a channel is worth.
Cycles longer than any attribution window
A contract signed four quarters after the click still credits that campaign.
Defensible in a board pack
Only exact matches count automatically; unmatched revenue is shown, never redistributed.
The number you can take into a budget meeting
Not impressions, not leads, not cost per click. Closed revenue, by the channel that produced it, for a period you choose — with the portion we could not trace shown rather than quietly shared out across your paid channels.
FY2026
Total revenue $6,200,000
Attributed to a channel $3,100,000 50% of revenue
Average deal $3,160
Match rate 75%
| Channel | Sales | Revenue | Share |
|---|---|---|---|
| Content & SEO | 412 | $1,302,000 | |
| Congresses & events | 334 | $1,054,000 | |
| Email marketing | 236 | $744,000 | |
| Direct / Unknown | 982 | $3,100,000 |
A first order is the beginning of a reordering account
A laboratory that orders once will typically reorder for years. Attribution that credits only the first order misprices every acquisition channel the business has.
Because the match is on the account, every reorder credits the original channel — which normally reveals that content and technical resources, not paid media, produce the accounts that keep ordering.
Technical content is the channel, and it looks like a cost centre
Application notes, protocols and technical documentation are what scientists actually use to choose a supplier, and they are budgeted as content rather than as acquisition.
With download or registration lists uploaded as source files, technical content ranks on order revenue against paid media. In this sector it usually wins, and being able to show that protects the budget.
What changes when you can prove it
You stop defending the budget and start growing it
"We generated 400 leads" invites an argument. "This channel closed $186,400 last quarter, here is the reconciliation" ends one. The teams that can show closed revenue by channel are the teams that get the next increase approved, because they are asking with evidence rather than with conviction.
You can cut the wrong channel without a fight
Killing spend is politically harder than adding it, because someone always owns the channel being cut. A number that reconciles to the sales export takes the argument out of the room — you are not overruling a colleague's judgement, you are reading the same ledger they are.
Your reporting survives the finance review
Platform-reported conversions do not reconcile to revenue, and eventually someone in finance notices. Reporting built from your own closed-sales export starts from the number finance already trusts, which is why it holds up when it is checked.
You answer in an afternoon, not a quarter
Because this reconciles exports rather than tracking visitors, it works on months that have already closed. You are not instrumenting now to learn something in ninety days — you can answer for last quarter today, which is usually when the question is being asked.
What pharma & life sciences usually push back on
Our customers reorder for years.
Which is why reorders must credit the original channel. That is where the value of an acquisition actually is.
We sell to institutions.
Matching works on the institutional contact's email; the account name can be carried as a column.
We operate in a regulated, audited environment.
Nothing is inferred and nothing is redistributed. Every counted match traces back to two records you supplied.
Pricing
Flat monthly pricing with no per-call, per-minute or per-form fees. The number here is the number on the invoice. Most pharma & life sciences land on Enterprise — ten seats for the team and the highest monthly record allowance, since a year of closed deals is a lot of rows.
Starter
A single business getting started
$49/mo
billed monthly
- 1 workspace · 1 seat
- 500 sales records / month
- 6-month saved history
- Phone + email matching with confidence tiers
- Assisted column mapping
- Your logo on every report
- CSV export
Growth
Most popularA business scaling ad spend
$199/mo
billed monthly
- 1 workspace · 2 seats
- 5,000 sales records / month
- 13-month history (year over year)
- Campaign drill-down and period comparison
- PDF + shareable read-only report
- Your logo on every report
- Priority support
Enterprise
One business closing at volume
$499/mo
billed monthly
- 1 workspace · 10 seats
- 25,000 sales records / month (+$49 per 10,000)
- 24-month history
- Campaign drill-down and period comparison
- Your logo on every report
- Roles, permissions and guided onboarding
Agency
Reporting on many clients at once
$799/mo
billed monthly
- 10 client workspaces (+$25/mo each)
- 10 seats
- 10,000 sales records / month per workspace
- 24-month history
- White-label reports — our mark removed entirely
- Roles, permissions and guided onboarding
Questions pharma & life sciences ask
Orders: a contact email, the order value, and a date.
Stop guessing which ads pay off.
Upload two exports and see your real revenue by channel in minutes. Three days free, no card.
Start free